Get our free mobile app

If you know anyone with a peanut allergy, you know that it's a very serious condition which could quickly result in severe illness and even death. Those with a peanut allergy have to literally scrutinize every thing they eat or certain foods that they're around in order to avoid disaster. According to Pubmed.org "Peanut and/or TN allergy affects approximately 1.1% of the general population, or about 3 million Americans, representing a significant health concern.", so that means there's potentially 3 million people and even more worldwide who can potentially benefit from a trial being done right here in Buffalo, New York.

Intrommune Therapeutics, a New York city based biotech company is taking on the challenge of creating a toothpaste that can help those affected with peanut allergies and they're currently conducting human trials right in our own backyard. According to their website "Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy." Their focus is Oral Mucosal Immunotherapy (OMIT) which delivers small doses of allergens into one's immune system via toothbrushing, which in return will hopefully help them build a tolerance thus less seriously affected by the targeted food allergy. Ingenious right?

In conjunction with a company that helps administer clinical trials called Circuit Clinical, there are currently eight patients enrolled in the trial of this specially formulated toothpaste and their goal for the trial is 40.  It's not immediately known as to when they'll being adding new participants but if successful, this could help millions of people to help live their lives without fear. For more information you can visit www.intrommune.com.